TiGenix raises €6.5 million in share placement

TiGenix NV has raised €6.5 million in a private placement of its shares to finance the continued roll-out of its cell therapy for knee injuries ChondroCelect. A total of 26 million new shares were placed via an accelerated bookbuilding procedure.